Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 15 March 2024 31 March 2025 31 March 2025 15564382 Dr Laura-Ann Hamilton iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15564382 2024-03-14 15564382 2025-03-31 15564382 2024-03-15 2025-03-31 15564382 frs-core:CurrentFinancialInstruments 2025-03-31 15564382 frs-bus:PrivateLimitedCompanyLtd 2024-03-15 2025-03-31 15564382 frs-bus:FilletedAccounts 2024-03-15 2025-03-31 15564382 frs-bus:Micro-entities 2024-03-15 2025-03-31 15564382 frs-bus:AuditExempt-NoAccountantsReport 2024-03-15 2025-03-31 15564382 frs-bus:Director1 2024-03-15 2025-03-31
Registered number: 15564382
Dr Laura-Ann McGill Ltd
Unaudited Financial Statements
For the Period 15 March 2024 to 31 March 2025
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 15564382
31 March 2025
£
Current assets 4,074
Creditors: Amounts Falling Due Within One Year (1,832 )
NET CURRENT ASSETS 2,242
TOTAL ASSETS LESS CURRENT LIABILITIES 2,242
Accruals and deferred income (480 )
NET ASSETS 1,762
CAPITAL AND RESERVES 1,762

Notes

1. General Information
Dr Laura-Ann McGill Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15564382 . The registered office is 39 Elm Grove Road, London, SW13 0BU.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Laura-Ann Hamilton
Director
02/06/2025